Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Advanced Gastric Cancer

Explore clinical trials studying HER2-positive Advanced Gastric Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Advanced Gastric Cancer trial results

Recruiting

A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

NCT05993234

Conditions
HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
Locations
  • KABEG Klinikum Klagenfurt am Wörthersee - Landeskrankenanstalten LKH Klagenfurt, Austria
  • Ordensklinikum Linz GmbH Barmherzige Schwestern Linz, Austria
  • Universitätsklinikum St. Pölten - Lilienfeld Sankt Pölten, Austria
  • Medizinische Universität Wien Vienna, Austria
View all 76 locations
View Trial Details

Related conditions